Company Profile
Avalanche Biotechnologies, Inc.
Company Overview
Founded in 2006, Avalanche is a privately held biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related macular degeneration (AMD), as well as other ophthalmologic disorders, such as diabetic retinopathy, retinal degeneration, and glaucoma.
Notable Products / Brands
The Ocular BioFactoryTM